Abbott Laboratories' medical device business is executing well, with double-digit growth in structural heart and diabetes.
Discover last week's top S&P 500 healthcare gainers, major market stories, and groundbreaking pharma deals, including weight-loss drug updates.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback